IL17A and inflammatory bowel disease: Our results suggest that production of IL-17 by CD4+ T cells may be a key mediator of IBD in humans, and that loss of Hem1 specifically in CD4+ T cells may contribute to intestinal disease in Hem1-deficient children by secreting IL-17.